INTRODUCTION
Sleep is an evolutionarily conserved behavioral state whose regulation is poorly understood (Sehgal and Mignot, 2011) . A key model postulates regulation by a homeostatic process that responds to internal cues for sleep need and a circadian process that responds to external cues (Borbé ly, 1982) . Several lines of evidence suggest that accumulation of extracellular adenosine in specific brain regions plays an important role in the homeostatic mechanism, although it is clear that other factors are also required (reviewed in Brown et al., 2012) . However, while mechanisms that regulate the circadian clock are well characterized (Fisher et al., 2013) , molecules that transmit circadian information to regulate sleep are largely unknown.
Melatonin is an attractive candidate for mediating the circadian process because the clock regulates its production (Klein, 2007) and it induces sleep in some contexts (Fisher et al., 2013) . However, despite decades of study and widespread use, the role of melatonin in regulating sleep is controversial (Fisher et al., 2013) . Exogenous melatonin is reported to have sleep-promoting effects in diurnal vertebrates including humans (Brzezinski et al., 2005; Zhdanova, 2005) , nonhuman primates (Zhdanova et al., 2002) , domesticated cats (Goldstein and Pavel, 1981) , birds (Mintz et al., 1998) , and zebrafish (Zhdanova et al., 2001) . However, others failed to observe this effect (Buscemi et al., 2006; van den Heuvel et al., 2005) , and its endogenous role in any animal is unknown. Exogenous melatonin can entrain (Lockley et al., 2000; Sack et al., 2000) and phase shift (Lewy et al., 1992 ) the circadian clock in some contexts, and melatonin has been called a regulator of circadian rhythms (Elbaz et al., 2013) . Indeed, melatonin has been proposed to promote sleep indirectly by phase advancing the circadian clock (Arendt, 2003) or by inhibiting the circadian drive for wakefulness (Scheer and Czeisler, 2005) . However, these hypotheses are based on exogenous melatonin. Determining melatonin's role in sleep is complicated by its production at night in both diurnal and nocturnal animals, and because most laboratory mouse strains produce little or no melatonin (Goto et al., 1989) . As a result, studies have relied on pharmacological approaches that have produced inconsistent results (Fisher et al., 2013) . To determine whether endogenous melatonin regulates sleep in a diurnal vertebrate, we analyzed melatonin function in the zebrafish, whose circadian clock and sleep regulation are conserved with mammals (Elbaz et al., 2013) .
RESULTS
Melatonin is produced in the zebrafish pineal gland at night under control of the circadian clock (Kazimi and Cahill, 1999) , as in mammals. To determine whether endogenous melatonin is required for sleep, we generated zebrafish with a predicted null mutation in arylalkylamine N-acetyltransferase 2 (aanat2) (Figure S1A) , which is required for melatonin synthesis in the pineal gland (Klein, 2007) . We found that wild-type (WT) larvae in 14:10 hr light:dark (LD) conditions had high melatonin levels at night and low levels during the day, while aanat2 homozygous mutants (aanat2 À/À ) produced little to no melatonin ( Figure S1B ). To determine whether melatonin is required for sleep, we used a videotracking assay (Prober et al., 2006) to compare sleep/ wake behaviors of aanat2 À/À larvae to their aanat2 +/À and WT siblings. We found that all three genotypes exhibited similar daytime amounts of sleep and activity ( Figures 1A-1C and 1E ). However, at night, aanat2 À/À larvae slept almost half as much and were three times more active than controls ( Figures 1A, 1B , 1D, and 1F). Decreased nighttime sleep was due mainly to a decrease in sleep bout length and a corresponding increase in wake bout length, with little effect on bout number (Figures S1F, S1H, and S1L). Sleep latency (time between lights out and sleep) at night was also longer for aanat2 À/À larvae ( Figure S1J ).
These results demonstrate that endogenous melatonin promotes initiation and maintenance of nighttime sleep in a diurnal vertebrate. Serotonin is acetylated by AANAT to form acetylserotonin, which is methylated to form melatonin. Loss of aanat2 may thus elevate serotonin levels in the pineal gland. Consistent with mammals (Borjigin et al., 2012) , we found that serotonin levels are higher in the pineal gland at night compared to the day in aanat2 +/À larvae (Figures S1C and S1D Zebrafish have a second aanat ortholog (aanat1) that is expressed in the retina (Appelbaum et al., 2006) . To test whether aanat1 is partially redundant with aanat2 in regulating sleep, we generated zebrafish with a predicted null mutation in aanat1 ( Figure S1A ). The behavioral phenotype of aanat1
larvae was indistinguishable from that of aanat2 À/À larvae (data not shown), suggesting that aanat1 is not required for sleep. Since aanat2 À/À larvae sleep less at night, we hypothesized that their arousal threshold might be reduced. To test this hypothesis, we applied a mechanoacoustic stimulus (Woods et al., 2014) at night at 1 min intervals at a range of intensities. Surprisingly, we found that aanat2 À/À larvae and their sibling controls exhibited similar half-maximal response probabilities (log(probability) = 1.17 ± 0.03, 1.15 ± 0.03 and 1.16 ± 0.04 for aanat2
, aanat2 +/À , and aanat2 +/+ , respectively; p = 0.92 by extra sum-of-squares F test) ( Figure S1M ), indicating that aanat2 À/À larvae have a normal arousal threshold. We next asked whether sleeping aanat2 À/À larvae are more likely to awaken in response to a stimulus, since light sleep is often a feature of insomnia. To test this hypothesis, we stimulated larvae every 5 min, allowing larvae to re-enter sleep after each stimulus. We used a tap strength at which 50% of larvae normally respond. There was no significant difference among the three genotypes (p = 0.43 by one-way ANOVA) ( Figure S1N ). Thus, although aanat2 À/À larvae sleep less at night, their arousal threshold and sleep depth are similar to controls, suggesting that their sleep defect is not caused by hyperarousal.
As an alternative approach to deplete melatonin, we ablated melatonin-producing cells. We generated transgenic zebrafish in which the aanat2 promoter drives expression of cyan fluorescent protein fused to nitroreductase (CFP-NTR), a bacterial protein that converts the inert pro-drug metronidazole (MTZ) into a potent DNA cross-linking agent that causes cell-autonomous death (Curado et al., 2007) . CFP-NTR was expressed exclusively in aanat2-expressing pineal gland cells ( Figures S2A and S2B ), which developed normally but underwent cell death upon Melatonin has been proposed to promote sleep indirectly, by phase advancing the circadian clock (Arendt, 2003) or inhibiting the circadian drive for wakefulness (Scheer and Czeisler, 2005) . To determine whether the sleep-promoting role of endogenous melatonin results from effects on the circadian clock, we raised and tested aanat2 À/À larvae in the dark (DD), resulting in arrhythmic animals lacking overt behavioral or molecular circadian rhythms (Figures 2A-2F , S3G, and S3H) (Kaneko and Cahill, 2005) . To determine whether the arrhythmia observed in DD is due to arrested or asynchronous cellular circadian clocks (Dekens and Whitmore, 2008), we performed fluorescent in situ hybridization for the clock gene per1b (Figures S3I-S3Q ). If the lack of overt rhythms is caused by arrested clocks, per1b should be expressed similarly at all circadian time points. However, if it results from asynchronous clocks, expression should be more heterogeneous in larvae raised in DD than in those raised in LD. Furthermore, for asynchronous clocks, the average fluorescence intensity among many cells in DD should be lower than the peak level in LD. We found that per1b expression oscillates throughout the brain in LD ( Figures S3I, S3K , S3M, and S3O) with phasing consistent with data from reverse-transcription quantitative PCR (RT-qPCR) ( Figure S3G ). In contrast, per1b is expressed at a similar level at all circadian time points in larvae raised in DD ( Figure S3J , S3L, S3N, and S3P). Quantification of fluorescence intensity in the hypothalamus showed that average per1b levels in DD are similar to peak levels in LD ( Figure S3Q ). Quantification in the forebrain and midbrain produced similar results (data not shown). These results suggest that raising larvae in DD abolishes circadian rhythms at the cellular level. Under these conditions, aanat2 À/À larvae exhibited continuously decreased sleep and increased activity (Figures 2A-2F ). The magnitude of the difference was similar to that observed at night in LD ( Figures 1A-1F ) and was again due to a decrease in sleep bout length and corresponding increase in wake bout length ( Figures S3A-S3F ). This phenotype was also rescued by exogenous melatonin ( Figures 2G-2L ). These results suggest that endogenous melatonin promotes sleep directly rather than via the circadian clock in zebrafish. Having established that melatonin is required for sleep at night, we next asked whether melatonin is required for normal circadian rhythms. Studies in humans, nonhuman primates, and rodents have shown that exogenous melatonin can phase shift (Lewy et al., 1992) and entrain (Lockley et al., 2000; Sack et al., 2000) the circadian clock. However, loss of the pineal gland, and thus melatonin production, produces inconsistent results (Arendt, 2003) . While pinealectomy in some species of fish, birds, and reptiles affects circadian rhythms (Underwood, 2001) , it is unclear whether this is due to loss of melatonin. We tested this hypothesis using two approaches. We first asked whether melatonin is required for behavioral circadian rhythms using the videotracker assay. To monitor circadian rhythms in ''freerunning'' conditions, we entrained larvae in LD and then shifted them to DD. In these conditions, WT larvae maintain molecular and behavioral rhythms ( Figures S4A, S4B, S4K , and S4L) (Kaneko and Cahill, 2005) . While aanat2 À/À larvae had a smaller circadian amplitude due to increased locomotor activity during subjective night ( Figures 3A, 3B , S4A, and S4H), the period length and phase were similar to controls ( Figures 3C and 3D) . Second, we used transgenic fish in which the period 3 promoter regulates expression of luciferase (Tg(per3:luc) ), an in vivo reporter of molecular rhythms in intact larvae (Kaneko and Cahill, 2005) . We found that per3:luc amplitude, period length, and phase were not significantly different for any genotype ( Figures  3E-3H ). To confirm this result, we isolated RNA from WT and aanat2 À/À larvae and performed RT-qPCR for the circadian clock genes per1b and arntl1a. Circadian oscillation of both genes was indistinguishable between WT and aanat2 À/À ( Figures S4K and   S4L ), indicating that aanat2 À/À larvae have normal molecular rhythms. Together with the observation that aanat2 À/À larvae exhibit normal locomotor activity period length and phase in LD ( Figure 1A ), this indicates that endogenous melatonin is not required to initiate or maintain circadian rhythms. We conclude that melatonin functions downstream of the circadian clock to promote sleep in zebrafish.
Our results suggest that melatonin may mediate process C, which determines when sleep occurs during the circadian cycle (Borbé ly, 1982) . To address this possibility, we entrained larvae in LD and transferred them to DD to remove the masking effects of light on behavior. Under these conditions, aanat2 À/À larvae, but not sibling controls, exhibited similar amounts of sleep during subjective day and night (Figures 4A-4C ), despite the maintenance of normal molecular rhythms ( Figures 3E-3F , S4K, and S4L). This indicates that melatonin is required for circadian regulation of sleep. Combined with the observation that exogenous melatonin is sufficient to induce daytime sleep ( Figures 1H and  1I ) (Zhdanova et al., 2001) , this suggests that melatonin mediates process C in zebrafish larvae. Exogenous melatonin can induce adenosine production in the mammalian forebrain (Zamorskii and Pishak, 2003) . To test whether adenosine mediates sleep promotion by melatonin, we treated aanat2 À/À larvae and their aanat2 +/À siblings with the adenosine receptor agonist 5 0 -N-ethylcarboxamido-adenosine (NECA). NECA treatment decreased locomotor activity in aanat2 +/À larvae during the day ( Figures 4D and S4M ) but had no effect on activity or sleep at night (Figures 4D-4G ; arrows indicate transient artifacts caused by pipetting compounds into the plate), presumably because adenosine receptors are maximally active at night. In contrast, NECA increased sleep and decreased activity at night for aanat2 À/À larvae to levels similar to their aanat2 +/À siblings, ( Figures 4F and 4G) , thus rescuing the mutant phenotype. As an alternative approach to modulate adenosine signaling, we treated larvae with ABT702, a small molecule inhibitor of adenosine kinase that increases extracellular adenosine levels, and thus adenosine signaling (Brown et al., 2012) . Similar to NECA, ABT702 ( Figure S4N ) had no effect on locomotor activity or sleep of aanat2 +/À larvae at night but rescued the activity and sleep phenotypes of aanat2 À/À larvae See also Figure S4 .
( Figures S4P-S4S ). These results suggest that melatonin may promote sleep, at least in part, by inducing adenosine signaling. To test whether these drugs failed to increase sleep at night in aanat2 +/À larvae because they were already sleeping maximally, we induced sleep via a different mechanism. Histamine is an arousing neuromodulator via mechanisms that are not well understood (Panula and Nuutinen, 2013) . Inhibition of the histamine 1 receptor (H1R) is sedating in mammals (Panula and Nuutinen, 2013) and zebrafish (Renier et al., 2007) . In contrast to NECA and ABT702, the H1R antagonist pyrilamine increased sleep and decreased activity in both aanat2 À/À and aanat2 +/À larvae to a similar extent ( Figures 4H-4K and S4O ). This indicates that the failure of NECA to increase nighttime sleep in aanat2 +/À larvae was not because the larvae were already sleeping maximally and suggests that histamine acts parallel to, rather than downstream of, melatonin in regulating sleep. Together, our results are consistent with a model in which adenosine acts downstream of melatonin to promote sleep at night, thus potentially linking homeostatic and circadian regulation of sleep ( Figure S4T ).
DISCUSSION
Melatonin is widely used as a sleep aid and has been cited as a regulator of circadian rhythms (Elbaz et al., 2013) . However, despite decades of study, the role of melatonin in regulating sleep and circadian rhythms is controversial (Fisher et al., 2013) and the function of endogenous melatonin is unknown.
Here we describe the first diurnal vertebrate genetic loss-offunction model for melatonin. We show that aanat2 À/À zebrafish larvae take twice as long to fall asleep and sleep only half as much as controls at night in LD conditions. This effect is surprisingly large since exogenous melatonin has relatively subtle sleep promoting effects in humans compared to prescribed hypnotics (Brzezinski et al., 2005; Buscemi et al., 2006) , which has led some to argue that melatonin is not an important sleep regulator (van den Heuvel et al., 2005) . However, most hypnotics inhibit neuronal activity throughout the brain by activating GABA A receptors, which is not a physiologically relevant mechanism of sleep promotion (Zhdanova, 2005) . Indeed, such an overpowering mechanism of sleep induction would be maladaptive. Furthermore, while exogenous melatonin may be a relatively weak sedative, it does not necessarily follow that endogenous melatonin does not play an important role in sleep. Comparing the importance of endogenous melatonin in humans and zebrafish will require more potent and specific melatonin receptor antagonists. While melatonin may play a more important role in promoting sleep in zebrafish, our results demonstrate that endogenous melatonin plays a significant role in promoting initiation and maintenance of sleep at night in a diurnal vertebrate. It has been proposed that melatonin promotes sleep indirectly by phase advancing the circadian clock (Arendt, 2003) or inhibiting the circadian drive for wakefulness (Scheer and Czeisler, 2005) . If these hypotheses are correct, aanat2 À/À larvae should have little or no sleep phenotype in the absence of entrained circadian rhythms. We tested this hypothesis by raising larvae in constant darkness, which abolished cellular circadian oscillations, at least in the brain. The aanat2 À/À sleep phenotype persisted under these conditions, suggesting that endogenous melatonin does not promote sleep by modulating the circadian clock but rather directly affects the sleep regulatory system. Indeed, while exogenous melatonin can entrain the circadian clock in free-running animals (Lockley et al., 2000; Sack et al., 2000) and phase shift the clock in some contexts (Lewy et al., 1992) , we found that endogenous melatonin is not required to initiate or maintain molecular or behavioral circadian rhythms in zebrafish. This observation does not support the hypothesis, based on exogenous melatonin, that endogenous melatonin regulates circadian rhythms (Elbaz et al., 2013) . Rather, our data suggest that melatonin acts downstream of the clock to promote sleep. A prominent model proposes that sleep is regulated by a homeostatic process responding to internal cues for sleep need (process S) and a circadian process responding to external cues (process C) (Borbé ly, 1982) . Evidence in mammals suggests that factors such as adenosine, nitric oxide, and prostaglandin D2 play important roles in mediating the homeostatic process (reviewed in Brown et al., 2012) . However, while the circadian clock mechanism has been described in detail (Fisher et al., 2013) , molecules that convey circadian information to regulate sleep are largely unknown. A factor mediating process C should fulfill three criteria. First, the clock should regulate the level or activity of the factor. Second, administration of the factor should induce sleep during the circadian waking period, but not the sleep period. Third, loss of the factor should abolish circadian regulation of sleep. Peptides whose expression oscillates in a circadian manner, and whose overexpression inhibits activity or promotes sleep during the circadian waking period, have been identified in nocturnal rodents, including cardiotrophinlike cytokine (Kraves and Weitz, 2006) , transforming growth factor alpha (Kramer et al., 2001) , and prokineticin 2 (Cheng et al., 2002) . However, loss-of-function studies have revealed little or no effect on the circadian regulation of activity or sleep (Hu et al., 2007; Kraves and Weitz, 2006; Li et al., 2006; Roberts et al., 2006) . Melatonin is an alternative candidate for mediating process C since, similar to these peptides, the circadian clock regulates its production (Klein, 2007) and it can induce sleep in some contexts (Fisher et al., 2013) . Indeed, exogenous melatonin potently increases sleep and decreases locomotor activity in zebrafish larvae during the day ( Figures 1G-1L) (Zhdanova et al., 2001) , and circadian regulation of sleep is abolished in aanat2 À/À larvae. These results suggest that melatonin mediates process C in the diurnal zebrafish animal model. This discovery may have important implications for the treatment of sleep and circadian rhythm disorders in humans. Because melatonin is produced at night in diurnal and nocturnal animals, and administration of physiological levels of melatonin does not promote sleep in nocturnal animals (Fisher et al., 2013) , nocturnal and diurnal animals probably use different mechanisms for circadian regulation of sleep (Zhdanova, 2005) . This idea is supported by the observation that most nocturnal mouse strains used for genetic studies produce little or no melatonin (Goto et al., 1989) yet have circadian control of sleep. Mutation of aanat in melatonin-proficient nocturnal and diurnal mammals will clarify melatonin's role in regulating mammalian sleep.
An open question raised by the two-process model (Borbé ly, 1982) is how homeostatic and circadian cues are integrated. Similar to melatonin, we found that activating adenosine signaling promotes sleep and inhibits activity during the day but has no effect on sleep at night in WT (data not shown) and aanat2 +/À larvae. In contrast, activating adenosine signaling increases sleep and decreases activity at night in aanat2 À/À larvae to the same level as their aanat2 +/À siblings. This result is unlikely due to a ceiling effect for sleep or parallel modulation of sleep by melatonin and adenosine because increasing nighttime sleep using a different approach, using a histamine H1R antagonist, increases nighttime sleep for both aanat2 +/À and aanat2 À/À larvae to a similar extent. These results suggest the sleep-promoting effect of endogenous melatonin may be mediated, at least in part, by adenosine signaling, and suggest a potential mechanism linking homeostatic and circadian regulation of sleep. This hypothesis must be further tested using genetics and measurements of adenosine levels, which will be challenging in the zebrafish due to its large number of adenosine receptor genes and its small brain size. Application of genome editing technologies to diurnal melatonin-proficient mammals would allow the use of genetics and measurement of adenosine levels using available technologies (Porkka-Heiskanen et al., 1997; Schmitt et al., 2012) . Finally, we note that reduced melatonin levels are associated with aging, mood disorders, and autism (Hardeland, 2012 ). An improved understanding of how endogenous melatonin interacts with the sleep system and other aspects of physiology using the aanat2 mutant may lead to novel therapies for these disorders.
EXPERIMENTAL PROCEDURES
Detailed methods are in Supplemental Experimental Procedures. Mutant zebrafish were generated using TALEN and CRISPR/Cas9 technologies. Videotracker behavioral experiments were performed as described (Prober et al., 2006) . A period of 1 or more min with no movement was defined as sleep because it is associated with an increased arousal threshold (Prober et al., 2006) . Arousal threshold was assayed by monitoring locomotor activity in response to a mechanoacoustic stimulus. Ablation of pineal gland cells (Curado et al., 2007) and per3:luc experiments (Kaneko and Cahill, 2005) were performed as described. 
